1. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
- Author
-
Sionis A, Sionis Green A, Manito Lorite N, Bueno H, Coca Payeras A, Díaz Molina B, González Juanatey JR, Ruilope Urioste LM, Zamorano Gómez JL, Almenar Bonet L, Ariza Solé A, Bover Freire R, Lambert Rodríguez JL, López de Sá E, López Fernández S, Martín Asenjo R, Mirabet Pérez S, Pascual Figal D, Segovia Cubero J, Varela Román A, San Román Calvar JA, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marin Ortuño F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis Green A, and Vázquez García R
- Subjects
- Acute Disease, Adrenergic beta-Antagonists therapeutic use, Aminobutyrates therapeutic use, Angiotensin Receptor Antagonists therapeutic use, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Benzazepines therapeutic use, Biphenyl Compounds, Chronic Disease, Drug Combinations, Early Medical Intervention, Echocardiography, Europe, Heart Failure blood, Heart Failure diagnosis, Humans, Ivabradine, Mineralocorticoid Receptor Antagonists therapeutic use, Natriuretic Peptides blood, Spain, Stroke Volume, Tetrazoles therapeutic use, Valsartan, Algorithms, Cardiac Resynchronization Therapy, Cardiovascular Agents therapeutic use, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable, Extracorporeal Membrane Oxygenation, Heart Failure therapy, Practice Guidelines as Topic
- Published
- 2016
- Full Text
- View/download PDF